No.1 pharmaceutical company in India, Dr Reddy’s Laboratories Limited has posted a consolidated net profit for the period Q4 (ending Mar 11) of the current fiscal (FY10-11). During the said quarter, consolidated net profit drops 34.8% to Rs 165 crores in comparison to Rs 253 crores profit of Q4 (ending Mar 10) of previous year (FY09-10). Dr. Reddy’s Laboratories is an integrated pharmaceutical company focused on providing medicines through its three business segments: Global Generics segment, Pharmaceutical Services and Active Ingredients (PSAI) segment and Proprietary Products segment.
The company informed the share market (BSE/NSE) that the total income/sales rose 7.09% to Rs 1375 crore in Q4 (ending Mar 2011) of the current fiscal (FY10-11) when compared with the same quarter Q4 (ending Mar 2010) of previous year (FY09-10). Total income was Rs 1284 crores in last year’s quarter Q4.
Share’s Data :-
BSE Code : 500164
Mkt. Cap : Rs 28,010.21 Crores
Dr Reddy’s Laboratories Ltd. share’s CMP is Rs 1,655.45 on 13th May 2011.
Stay tuned to BelltheBull Blog for more news on Dr Reddy’s Laboratories Limited !Google+